Nov 6 (Reuters) - Acerus Pharmaceuticals Corporation ASP.TO :
* ACERUS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS
* ACERUS PHARMACEUTICALS CORPORATION - INCREASED QTRLY PRODUCT REVENUE BY 16% TO $1.6 MILLION VERSUS $1.4 MILLION IN SAME THREE-MONTH PERIOD IN PRIOR YEAR
* ACERUS PHARMACEUTICALS CORPORATION - TOTAL REVENUE FOR THREE MONTH ENDED SEPT 30, WAS $1.6 MILLION VERSUS $1.4 MILLION FOR SAME PRIOR YEAR PERIODS
* ACERUS PHARMACEUTICALS CORPORATION - QTRLY LOSS PER SHARE $0.01